Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer carbonate for cardiovascular structure and function in early chronic kidney disease
2008-003727-23Phase 2Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Dec 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of sevelamer carbonate in chronic kidney disease (CKD), sponsored by University Hospitals Birmingham. Primary endpoint: Reduction in left ventricular mass. Started Dec 2010; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-003727-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003727-23.